Ting Cheng
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Ting Cheng has a total of 46 co-authors. Here are the top co-authors by number of shared publications:
Geng Li
Second Affiliated Hospital of Guangzhou University of Chinese Medicine (Guangdong Provincial Hospital of Chinese Medicine), Guangzhou, China
4 shared publicationsLi Zhou
Second Affiliated Hospital of Guangzhou University of Chinese Medicine (Guangdong Provincial Hospital of Chinese Medicine), Guangzhou, China
4 shared publications- Zehuai Wen
Guangdong Provincial Hospital of Chinese Medicine (Second Affiliated Hospital of Guangzhou University of Chinese Medicine) Guangdong Provincial Academy of Chinese Medical Sciences Guangzhou China
4 shared publications Xingying Qiu
Second Clinical College of Guangzhou University of Chinese Medicine Guangzhou China
3 shared publicationsDongdong Yu
First Affiliated Hospital of Anhui University of Chinese Medicine, Hefei, China
2 shared publications- Dongdong Yu
The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong Province, China
2 shared publications
Latest Publications
- 14 July 2026
- Published by Elsevier in Phytomedicine
- Vol. 159, 158590
Bioactive compounds from traditional Chinese medicine for mitochondrial dysfunction-oriented nanodelivery in neurodegenerative diseases
- 14 July 2026
- Published by Elsevier in Phytomedicine
- Vol. 159, 158590
Bioactive compounds from traditional Chinese medicine for mitochondrial dysfunction-oriented nanodelivery in neurodegenerative diseases
- 1 January 2026
- Published by World Scientific Pub Co Pte Ltd in The American Journal of Chinese Medicine
- Vol. 54 (05) , 1475-1497
Targeting Ferroptosis: Effects and Mechanisms of Action of Berberine
Ferroptosis, a form of regulated cell death characterized by iron-dependent lipid peroxidation, plays a critical role in various diseases. Berberine, a bioactive compound from plants such as Coptis chinensis, tree turmeric, and barberry, exhibits bidirectional regulation of ferroptosis, but its systemic mechanisms remain unclear. This review summarizes berberine’s effects through multiple signaling pathways, emphasizing context-dependent mechanisms, tissue-specific accumulation, and therapeutic potential. Relevant literature was retrieved from PubMed, Web of Science, CNKI, and ScienceDirect. Berberine modulates ferroptosis via iron homeostasis, lipid peroxidation, the System Xc − /GSH/GPX4 anti-oxidant system, and mitochondrial function, involving NRF2, p53, AMPK, PI3K/Akt, and MAPK pathways. It promotes ferroptosis in tumors and fibrotic diseases but inhibits it in cardiovascular, metabolic, and neurological disorders, alleviating tissue damage. Nano-delivery systems and structural optimization enhance bioavailability and targeting, demonstrating therapeutic efficacy and biosafety. Berberine’s multi-target, bidirectional regulation shows promising clinical potential, warranting further mechanistic and delivery-focused studies.
- 1 January 2026
- Published by World Scientific Pub Co Pte Ltd in The American Journal of Chinese Medicine
- Vol. 54 (05) , 1475-1497
Targeting Ferroptosis: Effects and Mechanisms of Action of Berberine
Ferroptosis, a form of regulated cell death characterized by iron-dependent lipid peroxidation, plays a critical role in various diseases. Berberine, a bioactive compound from plants such as Coptis chinensis, tree turmeric, and barberry, exhibits bidirectional regulation of ferroptosis, but its systemic mechanisms remain unclear. This review summarizes berberine’s effects through multiple signaling pathways, emphasizing context-dependent mechanisms, tissue-specific accumulation, and therapeutic potential. Relevant literature was retrieved from PubMed, Web of Science, CNKI, and ScienceDirect. Berberine modulates ferroptosis via iron homeostasis, lipid peroxidation, the System Xc − /GSH/GPX4 anti-oxidant system, and mitochondrial function, involving NRF2, p53, AMPK, PI3K/Akt, and MAPK pathways. It promotes ferroptosis in tumors and fibrotic diseases but inhibits it in cardiovascular, metabolic, and neurological disorders, alleviating tissue damage. Nano-delivery systems and structural optimization enhance bioavailability and targeting, demonstrating therapeutic efficacy and biosafety. Berberine’s multi-target, bidirectional regulation shows promising clinical potential, warranting further mechanistic and delivery-focused studies.
- 20 November 2025
- Published by Elsevier in Phytomedicine
- Vol. 149, 157567
Huoxiang Zhengqi oral liquid for irritable bowel syndrome with diarrhea: a multicenter, double-blind, randomized controlled trial
- 20 November 2025
- Published by Elsevier in Phytomedicine
- Vol. 149, 157567
Huoxiang Zhengqi oral liquid for irritable bowel syndrome with diarrhea: a multicenter, double-blind, randomized controlled trial
- Open Access
- 7 September 2025
- Published by Wiley in Food Science & Nutrition
- Vol. 13 (9)
Association of the Dietary Index for Gut Microbiota and Cardiovascular‐Kidney‐Metabolic Syndrome: The Mediation Effect of Phenotypic and Biological Age Acceleration, BMI , and BRI
The relationship between gut microbiota, diet, and cardiovascular‐kidney‐metabolic (CKM) health has attracted attention. However, the relationship between the dietary index for gut microbiota (DI‐GM) and CKM syndrome has not yet been studied. Patients diagnosed with CKM syndrome from the NHANES 2007–2018 data were included. Dietary recall data were used to calculate DI‐GM. Restricted cubic splines (RCS) were employed to explore nonlinear relationships and determine the threshold for DI‐GM. The relationship between DI‐GM and CKM syndrome was analyzed using weighted logistic regression. Further, potential mediating roles of phenotype age acceleration (PAA), biological age acceleration (BAA), body mass index (BMI), and body roundness index (BRI) were explored. Sensitivity analysis using inverse probability of treatment weighting (IPTW) was also conducted. A total of 7252 participants were included, with the high DI‐GM group as the reference. In the crude model, the risk of CKM syndrome in the low DI‐GM group was significantly higher (OR = 1.27, 95% CI = 1.09, 1.49, p < 0.05). This association remained significant in the fully adjusted model (OR = 1.34, 95% CI = 1.10, 1.64, p < 0.05). The results of the IPTW analysis were consistent with the above findings. In the association between DI‐GM and CKM syndrome, significant mediating effects were observed for PAA (mediated proportion (MP): 14.84%, p < 0.001), BAA (MP: 21.45%, p < 0.001), BMI (MP: 24.17%, p < 0.001), and BRI (MP: 35.85%, p < 0.001). Low DI‐GM is associated with an increased prevalence of CKM syndrome. PAA, BAA, BRI, and BMI significantly mediate the relationship between DI‐GM and CKM syndrome.
- 7 September 2025
- Published by Wiley in Food Science & Nutrition
- Vol. 13 (9)
Open AccessAssociation of the Dietary Index for Gut Microbiota and Cardiovascular‐Kidney‐Metabolic Syndrome: The Mediation Effect of Phenotypic and Biological Age Acceleration, BMI , and BRI
The relationship between gut microbiota, diet, and cardiovascular‐kidney‐metabolic (CKM) health has attracted attention. However, the relationship between the dietary index for gut microbiota (DI‐GM) and CKM syndrome has not yet been studied. Patients diagnosed with CKM syndrome from the NHANES 2007–2018 data were included. Dietary recall data were used to calculate DI‐GM. Restricted cubic splines (RCS) were employed to explore nonlinear relationships and determine the threshold for DI‐GM. The relationship between DI‐GM and CKM syndrome was analyzed using weighted logistic regression. Further, potential mediating roles of phenotype age acceleration (PAA), biological age acceleration (BAA), body mass index (BMI), and body roundness index (BRI) were explored. Sensitivity analysis using inverse probability of treatment weighting (IPTW) was also conducted. A total of 7252 participants were included, with the high DI‐GM group as the reference. In the crude model, the risk of CKM syndrome in the low DI‐GM group was significantly higher (OR = 1.27, 95% CI = 1.09, 1.49, p < 0.05). This association remained significant in the fully adjusted model (OR = 1.34, 95% CI = 1.10, 1.64, p < 0.05). The results of the IPTW analysis were consistent with the above findings. In the association between DI‐GM and CKM syndrome, significant mediating effects were observed for PAA (mediated proportion (MP): 14.84%, p < 0.001), BAA (MP: 21.45%, p < 0.001), BMI (MP: 24.17%, p < 0.001), and BRI (MP: 35.85%, p < 0.001). Low DI‐GM is associated with an increased prevalence of CKM syndrome. PAA, BAA, BRI, and BMI significantly mediate the relationship between DI‐GM and CKM syndrome.
- 20 August 2024
- Published by Taylor & Francis in Expert Opinion on Drug Safety
- Vol. 24 (11) , 1333-1340
Safety of proteasome inhibitor drugs for the treatment of multiple myeloma post-marketing: a pharmacovigilance investigation based on the FDA adverse event reporting system
The use of proteasome inhibitors (PIs), namely Bortezomib and Carfilzomib, revolutionized multiple myeloma (MM) treatment. Understanding their distinct adverse event (AE) profiles aids in tailored treatment plans. We analyzed FDA Adverse Event Reporting System (FAERS) data (Q1 2012-Q4 2023) for Bortezomib and Carfilzomib, utilizing reporting odds ratio (ROR), proportional reporting ratio (PRR), and Bayesian confidence propagation neural network (BCPNN). FAERS yielded 19,720 Bortezomib and 12,252 Carfilzomib AE reports. Males aged 45-65 exhibited higher AE susceptibility. Common AE systems included Infections, Nervous System Disorders, Blood Disorders, General Disorders, Cardiac Disorders, and Renal Disorders. New Bortezomib signals were sepsis and colitis. Carfilzomib exhibited elevated cardiac and renal toxicity but reduced peripheral neuropathy and thrombocytopenia. FAERS analysis revealed new AE signals (sepsis, colitis) for Bortezomib and highlighted Carfilzomib's heightened cardiac and renal risks compared to Bortezomib. Balancing PIs' benefits and risks is crucial for clinical decision-making.
- 20 August 2024
- Published by Taylor & Francis in Expert Opinion on Drug Safety
- Vol. 24 (11) , 1333-1340
Safety of proteasome inhibitor drugs for the treatment of multiple myeloma post-marketing: a pharmacovigilance investigation based on the FDA adverse event reporting system
The use of proteasome inhibitors (PIs), namely Bortezomib and Carfilzomib, revolutionized multiple myeloma (MM) treatment. Understanding their distinct adverse event (AE) profiles aids in tailored treatment plans. We analyzed FDA Adverse Event Reporting System (FAERS) data (Q1 2012-Q4 2023) for Bortezomib and Carfilzomib, utilizing reporting odds ratio (ROR), proportional reporting ratio (PRR), and Bayesian confidence propagation neural network (BCPNN). FAERS yielded 19,720 Bortezomib and 12,252 Carfilzomib AE reports. Males aged 45-65 exhibited higher AE susceptibility. Common AE systems included Infections, Nervous System Disorders, Blood Disorders, General Disorders, Cardiac Disorders, and Renal Disorders. New Bortezomib signals were sepsis and colitis. Carfilzomib exhibited elevated cardiac and renal toxicity but reduced peripheral neuropathy and thrombocytopenia. FAERS analysis revealed new AE signals (sepsis, colitis) for Bortezomib and highlighted Carfilzomib's heightened cardiac and renal risks compared to Bortezomib. Balancing PIs' benefits and risks is crucial for clinical decision-making.
- Open Access
- 25 March 2024
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 19 (3) , e0296936
The relationship between a series of inflammatory markers on the risk of heart failure in different gender groups: Analysis from NHANES 2015–2018
Background: A better understanding of the level-grade inflammation for the development and worsening of heart failure (HF) in different gender groups is an unmet need. We performed an updated analysis on the impact of a series of systemic inflammation markers on HF. Methods: This compensatory cross-sectional study enrolled participants from the National Health and Nutrition Examination Survey (NHANES) 2015–2018. HF was based on the self-reported questions. Univariate and multivariate logistic regression were used to investigate the association between systemic immune-inflammation index (SII), high sensitivity C-reactive protein (hs-CRP), lymphocyte-to-monocyte ratio (LMR), neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR) and HF. For patients of different genders, P for trend was used to analyze potential linear trend relationships and the restricted cubic splines (RCS) were used to describe non-linear relationships. The additive interaction was evaluated by the relative excess risk due to interaction (RERI), attributable proportion (AP), and the synergy index (SI). The multiplicative interaction was evaluated by odds ratio (OR) and 95% confidence interval (CI) of product-term. Results: A total of 5,830 participants from the NHANES database were divided into two groups: the HF group (n = 210) and the non-HF group (n = 5620). After gender stratification, hs-CRP (OR: 1.01, 95% CI: 1.00–1.03), SII (OR: 1.00, 95% CI: 1.00–1.01), NLR (OR: 1.22, 95% CI: 1.11–1.35) and LMR (OR: 0.79, 95% CI: 0.65–0.93) were independent meaningful factors for HF in males, there was no non-linear relationship between the three factors (SII, NLR, hs-CRP, all P for non-linear > 0.05) and the prevalence of HF, but we detected a non-linear relationship between LMR and the prevalence of HF in males (P for non-linear < 0.05). An additive interaction of hs-CRP and NLR on the risk of HF in males (RERI (OR): 0.67, 95% CI: 0.12–1.34; AP (OR): 0.14, 95% CI: 0.02–0.24; SI (OR): 1.22, 95% CI: 1.03–1.44). Conclusions: In summary, hs-CRP, NLR, and LMR are superior meaningful markers for HF in males. SII may be a meaningful systemic inflammation warning marker for HF, which needs to be discriminated against with caution. Only detected a non-linear relationship between LMR and the prevalence of HF in males. NLR and hs-CRP may have an additive interaction in the prevalence of male HF patients. The outcome compensated for previous studies that still needed more studies for validation.
- 25 March 2024
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 19 (3) , e0296936
Open AccessThe relationship between a series of inflammatory markers on the risk of heart failure in different gender groups: Analysis from NHANES 2015–2018
Background: A better understanding of the level-grade inflammation for the development and worsening of heart failure (HF) in different gender groups is an unmet need. We performed an updated analysis on the impact of a series of systemic inflammation markers on HF. Methods: This compensatory cross-sectional study enrolled participants from the National Health and Nutrition Examination Survey (NHANES) 2015–2018. HF was based on the self-reported questions. Univariate and multivariate logistic regression were used to investigate the association between systemic immune-inflammation index (SII), high sensitivity C-reactive protein (hs-CRP), lymphocyte-to-monocyte ratio (LMR), neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR) and HF. For patients of different genders, P for trend was used to analyze potential linear trend relationships and the restricted cubic splines (RCS) were used to describe non-linear relationships. The additive interaction was evaluated by the relative excess risk due to interaction (RERI), attributable proportion (AP), and the synergy index (SI). The multiplicative interaction was evaluated by odds ratio (OR) and 95% confidence interval (CI) of product-term. Results: A total of 5,830 participants from the NHANES database were divided into two groups: the HF group (n = 210) and the non-HF group (n = 5620). After gender stratification, hs-CRP (OR: 1.01, 95% CI: 1.00–1.03), SII (OR: 1.00, 95% CI: 1.00–1.01), NLR (OR: 1.22, 95% CI: 1.11–1.35) and LMR (OR: 0.79, 95% CI: 0.65–0.93) were independent meaningful factors for HF in males, there was no non-linear relationship between the three factors (SII, NLR, hs-CRP, all P for non-linear > 0.05) and the prevalence of HF, but we detected a non-linear relationship between LMR and the prevalence of HF in males (P for non-linear < 0.05). An additive interaction of hs-CRP and NLR on the risk of HF in males (RERI (OR): 0.67, 95% CI: 0.12–1.34; AP (OR): 0.14, 95% CI: 0.02–0.24; SI (OR): 1.22, 95% CI: 1.03–1.44). Conclusions: In summary, hs-CRP, NLR, and LMR are superior meaningful markers for HF in males. SII may be a meaningful systemic inflammation warning marker for HF, which needs to be discriminated against with caution. Only detected a non-linear relationship between LMR and the prevalence of HF in males. NLR and hs-CRP may have an additive interaction in the prevalence of male HF patients. The outcome compensated for previous studies that still needed more studies for validation.
- Open Access
- 6 March 2024
- Published by Wiley in Food Science & Nutrition
- Vol. 12 (6) , 3964-3972
Oily fish reduces the risk of acne by lowering fasting insulin levels: A Mendelian randomization study
Meat intake, particularly from oily fish, has been associated with various chronic diseases. However, its relationship with acne has always been controversial. Therefore, we have adopted Mendelian randomization (MR) analysis to investigate the causal relationship between different types of meat intake and acne. The exposure and outcome datasets for this study were obtained from the Integrative Epidemiology Unit (IEU) Open GWAS project. Seven datasets on meat intake were included, which consisted of non‐oily fish, oily fish, lamb/mutton, poultry, pork, beef, and processed meat. The main methods used for MR analysis were inverse variance weighted, weighted median, and MR‐egger. To ensure the accuracy of the results, heterogeneity, pleiotropy, and Mendelian randomization pleiotropy residual sum and outlier (MR‐PRESSO) analyses were conducted. Additionally, an analysis of four risk factors (fasting insulin, insulin resistance, total testosterone level, and estradiol level) was performed to investigate the underlying mechanisms linking statistically significant meat intake to acne. Oily fish intake was found to be a protective factor for acne (OR: 0.22, 95% CI: 0.10–0.49, p < .001), and it was also observed that oily fish intake can reduce the level of fasting insulin by the IVW method (OR: 0.89, 95% CI: 0.81–0.98, p = .02). No causal relationship was identified between other types of meat intake and acne. The intake of oily fish reduces the risk of acne by lowering fasting insulin levels.
- 6 March 2024
- Published by Wiley in Food Science & Nutrition
- Vol. 12 (6) , 3964-3972
Open AccessOily fish reduces the risk of acne by lowering fasting insulin levels: A Mendelian randomization study
Meat intake, particularly from oily fish, has been associated with various chronic diseases. However, its relationship with acne has always been controversial. Therefore, we have adopted Mendelian randomization (MR) analysis to investigate the causal relationship between different types of meat intake and acne. The exposure and outcome datasets for this study were obtained from the Integrative Epidemiology Unit (IEU) Open GWAS project. Seven datasets on meat intake were included, which consisted of non‐oily fish, oily fish, lamb/mutton, poultry, pork, beef, and processed meat. The main methods used for MR analysis were inverse variance weighted, weighted median, and MR‐egger. To ensure the accuracy of the results, heterogeneity, pleiotropy, and Mendelian randomization pleiotropy residual sum and outlier (MR‐PRESSO) analyses were conducted. Additionally, an analysis of four risk factors (fasting insulin, insulin resistance, total testosterone level, and estradiol level) was performed to investigate the underlying mechanisms linking statistically significant meat intake to acne. Oily fish intake was found to be a protective factor for acne (OR: 0.22, 95% CI: 0.10–0.49, p < .001), and it was also observed that oily fish intake can reduce the level of fasting insulin by the IVW method (OR: 0.89, 95% CI: 0.81–0.98, p = .02). No causal relationship was identified between other types of meat intake and acne. The intake of oily fish reduces the risk of acne by lowering fasting insulin levels.